Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer

J Natl Cancer Inst. 2005 Feb 2;97(3):235-6. doi: 10.1093/jnci/dji037.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Bone Neoplasms / prevention & control*
  • Bone Neoplasms / secondary
  • Diphosphonates / therapeutic use*
  • Humans
  • Imidazoles / therapeutic use*
  • Male
  • Prostatic Neoplasms / drug therapy*
  • Prostatic Neoplasms / metabolism
  • Prostatic Neoplasms / pathology*
  • Time Factors
  • Treatment Outcome
  • Zoledronic Acid

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid